Lazard Capital Starts Repros Therapeutics (RPRX) at Buy

February 5, 2013 6:40 AM EST Send to a Friend
Get Alerts RPRX Hot Sheet
Price: $8.75 -2.99%

Rating Summary:
    6 Buy, 1 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 11 | Down: 14 | New: 51
Trade RPRX Now!
Join SI Premium – FREE
Lazard Capital initiates coverage on Repros Therapeutics (NASDAQ: RPRX) with a Buy. PT $26.00.

For an analyst ratings summary and ratings history on Repros Therapeutics click here. For more ratings news on Repros Therapeutics click here.

Shares of Repros Therapeutics closed at $11.83 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage

Related Entities

Lazard

Add Your Comment